Wednesday, Aug. 29, 2018, AKRON: Cleveland Clinic Akron General recently appointed Rajesh R. Tampi, M.D., MS, DFAPA, as the new chair of the Department of Psychiatry and Psychology. Dr. Tampi, a resident of Strongsville, will also lead the section of Geriatric Psychiatry for the Department of Psychiatry and Psychology at Cleveland Clinic.

Takeda Pharmaceutical Company Limited (Takeda; TSE: 4502) and H. Lundbeck A/S (Lundbeck; LUN.CO, LUN DC, HLUYY) today announced the U.S. Food and Drug Administration (FDA) approved a supplemental new drug application for TRINTELLIX® (vortioxetine). TRINTELLIX is the first FDA-approved treatment for MDD where the U.S. labelling now includes data from the largest replicated clinical studies on an important aspect of cognitive function in acute major depressive disorder (MDD, depression). The FOCUS and CONNECT studies showed TRINTELLIX had a positive effect on processing speed, an important aspect of cognitive function that may be impaired in adult patients with acute MDD.

On February 6, AAGP released an official statement on President Trump’s executive order. “…[this] executive order puts further strain on the physician workforce in areas of dire need,” said AAGP President Daniel D. Sewell, MD. To read the entire statement, click here.

On February 6, AAGP released an official statement on President Trump’s executive order. “…[this] executive order puts further strain on the physician workforce in areas of dire need,” said AAGP President Daniel D. Sewell, MD. To read the entire statement, click here.

AAGP was recently informed of the WHO's ICD-11 proposal to transfer all dementia diagnoses from the Mental or Behavioral Health Disorder section to the Nervous System section. Click here to view AAGP's direct response.